FGEN Competitors & Alternatives
Compare FibroGen Inc with similar stocks in the same industry
Biotechnology
FGEN
Main Stock$9.71
Tradestie Score
43
Market Cap
$48.63M
Revenue Growth
7.7%
Analyst Upside
+342.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$6.49
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.05
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 63 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 57 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 42 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.15
|
$67.94M | - | 60 | Compare |
|
TPIC
TPIC
|
- | - | - | - | Compare |
|
AFMD
AFMD
|
- | - | - | - | Compare |
|
MEIP
MEIP
|
- | - | - | 49 | Compare |
More FGEN Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry